Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
1801747-67-6
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Jounce_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
vopratelimab
|
| gptkbp:intendedUse |
immunotherapy
|
| gptkbp:macromoleculeType |
IgG1 monoclonal antibody
|
| gptkbp:mechanismOfAction |
immune checkpoint modulation
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:ICOS
|
| gptkbp:UNII |
8Q1K1Q6Q1F
|
| gptkbp:bfsParent |
gptkb:Jounce
gptkb:Jounce_Therapeutics |
| gptkbp:bfsLayer |
7
|